Clinical trial shows bionic pancreas improves type 1 diabetes management compared to standard insulin delivery method
The pros and cons of telemental health care
29 September 2022Study finds folic acid treatment is associated with decreased risk of suicide attempts
29 September 2022Clinical trial shows bionic pancreas improves type 1 diabetes management compared to standard insulin delivery method
A device known as a bionic pancreas, which uses next-generation technology to automatically deliver insulin, was more effective at maintaining blood glucose (sugar) levels within normal range than standard-of-care management among people with type 1 diabetes, a new multicenter clinical trial has found. The trial, conducted partly at Nemours Children’s Health, Jacksonville, was published in the New England Journal of Medicine.
